JERECZEK, BARBARA ALICJA
JERECZEK, BARBARA ALICJA
Dipartimento di Oncologia ed Emato-Oncologia
Stable or not? unraveling the reliability of radiomic features in 4d-computed tomography in early-stage non-small cell lung cancer
2026 S. Volpe, A. Gaeta, M.G. Vincini, M. Zaffaroni, F. Mastroleo, S. Raimondi, M. Pepa, L.J. Isaksson, M. Cremonesi, D. La Torre, M. Guckenberger, F. Bellerba, R. Orecchia, S. Gandini, B.A. Jereczek-Fossa
Stereotactic Radioablation for Ventricular Tachycardia in Patients Untreatable by Catheter Ablation: Evidence of Efficacy, Safety, and Impact on Coronary Arteries
2026 C. Carbucicchio, M. Schiavone, G. Piperno, M.E. Mancini, F. Cattani, M. Sabatino, A. Ferrari, A. Bonomi, F. Marchetti, L. Bianchini, E. Rondi, E. Ventura, S. Mushtaq, V. Catto, R. Orecchia, G. Pompilio, C. Tondo, G. Pontone, B.A. Jereczek-Fossa
Proton therapy in breast cancer: bridging medical and radiation oncology
2026 D. Alterio, S. Dicuonzo, M. Zaffaroni, M.G. Vincini, P. Zagami, C. Criscitiello, F. Braga, E. Milovanova, M.C. Leonardi, P. Veronesi, A.M. Kirby, R. Orecchia, G. Curigliano, B.A. Jereczek-Fossa
Predictive Modelling of Service Building and Users Mobility Related Energy Consumption Through Machine Learning and Graph Based Analysis
2026 V. Bellandi, S. Siccardi, M.G. Vincini, F. Mastroleo, G. Marvaso, B.A. Jereczek‐fossa, E. Damiani
A Decade of Interventional Radiotherapy (Brachytherapy): Progress, Challenges, and Future Prospects – A Bibliometric Analysis
2026 F. Mastroleo, E. Milovanova, S. Durante, F. Gagliardi, M. Bilski, B. Fionda, L. Tagliaferri, A. Gomez-Iturriaga, A. Sturdza, A. Stewart, M. Borras-Osorio, M.R. Waddle, G. Marvaso, A. Vavassori, Ł. Kuncman, J. Fijuth, B.A. Jereczek-Fossa
Methodological issues in radiomics: impact on accuracy of MRI for predicting response to neoadjuvant chemotherapy in breast cancer
2025 S. Netti, O. D'Ecclesiis, F. Corso, F. Botta, D. Origgi, F. Pesapane, G.M. Agazzi, A. Rotili, A. Gaeta, E. Scalco, G. Rizzo, B.A. Jereczek-Fossa, E. Cassano, G. Curigliano, S. Gandini, S. Raimondi
Coronary artery calcium and cardiovascular risk factors analysis after radiotherapy for breast cancer (the CLARIFIER: a gender-based preventive medicine study)
2025 D. Trabattoni, M.C. Leonardi, M.E. Mancini, B.A. Jereczek-Fossa, F. Cattani, G. Santagostino Baldi, A. Bonomi, A. Galotta, S. Mushtaq, A. Annoni, D. Alio, M.G. Vincini, C.I. Fodor, L. La Grutta, P. Montorsi, G. Pontone
CT-Based Radiomics Enhance Respiratory Function Analysis for Lung SBRT
2025 A. Porazzi, M. Zaffaroni, V.E. Pierini, M. Giulia Vincini, A. Gaeta, S. Raimondi, L. Berton, L.J. Isaksson, F. Mastroleo, S. Gandini, M. Casiraghi, G. Piperno, L. Spaggiari, J. Guarize, S.M. Donghi, Ł. Kuncman, R. Orecchia, S. Volpe, B.A. Jereczek
Harnessing Baseline Radiomic Features in Early-Stage NSCLC: What Role in Clinical Outcome Modeling for SBRT Candidates?
2025 S. Volpe, M.G. Vincini, M. Zaffaroni, A. Gaeta, S. Raimondi, G. Piperno, J. Franzetti, F. Colombo, A.M. Camarda, F. Mastroleo, F. Botta, L. Spaggiari, S. Gandini, M. Guckenberger, R. Orecchia, M. Casiraghi, B.A. Jereczek-Fossa
RadiOnCOVID: Multicentric Analysis of the Impact of COVID-19 on Patients Undergoing Radiation Therapy in Italy
2025 A.E. Guerini, G. Marvaso, S. Tonoli, G. Corrao, M.A. Teriaca, M. Sepulcri, M. Scricciolo, A. Gava, S. Montrone, N. Giaj-Levra, B.N. Chiorda, G. Mantello, F. Fiorica, S. Borghesi, L. Belgioia, A. Caroli, A. Fiorentino, B.A. Jereczek-Fossa, S.M. Magrini, M. Buglione
Thermal ablation for local tumor recurrence after previous partial nephrectomy: Perioperative and oncological outcomes
2025 C. Vaccaro, F.A. Mistretta, M.L. Piccinelli, E. Lievore, L.M.I. Jannello, M. Fontana, M. Tozzi, P. Della Vigna, G. Bonomo, G. Varano, F. Mastroleo, G. Marvaso, B.A. Jereczek-Fossa, S. Luzzago, F. Orsi, G. Musi
A new application of computed tomography: stereotactic radiotherapy in the treatment of ventricular arrhythmias
2025 M.E. Mancini, F. Marchetti, S. Mushtaq, F. Cannata, M. Schiavone, C. Tondo, G. Piperno, B.A. Jereczek-Fossa, C. Carbucicchio, G. Pontone
Salvage Radiotherapy Following Nonradiotherapy Ablative Techniques for Primary Prostate Cancer: A Systematic Review and Meta-analysis
2025 O. Mohamad, L. Mose, M. Ahmadsei, R. Kouzy, C. Zamboglou, L. Nicosia, F. Alongi, T. Zilli, S. Arcangeli, G. Marvaso, B.A. Jereczek-Fossa, M. Guckenberger, D.M. Aebersold, M. Shelan
Precision Radiotherapy for Kidney Cancer: A Rising Ally in Multidisciplinary Care
2025 B.A. Jereczek-Fossa, F. Mastroleo, G. Marvaso
Interventional stereotactic radiotherapy (brachytherapy) for unresected brain metastases: Systematic review of outcome and toxicity
2025 M. Bilski, F. Mastroleo, L. Kuncman, P. Rogowski, S. Durante, C. Putzu, A. Chyrek, G. Marvaso, B. Fionda, L. Tagliaferii, J. Fijuth, A. Vavassori, R. Tolakanahalli, B.A. Jereczek-Fossa, R. Kotecha
Exploratory analysis of the professional quality of life in an Italian radiotherapy department: The role of empathy and alexithymia
2025 T. Burla, M. Zaffaroni, G. Marvaso, K. Mazzocco, G. Galli, M.G. Vincini, F. Mastroleo, M. Sarra Fiore, G. Pravettoni, B.A. Jereczek-Fossa
Metastasis-directed Therapy in the Management of Urothelial Carcinoma: A Systematic Review and Meta-analysis
2025 M. Miszczyk, M. Bilski, T. Koi, K. Konat-Baska, A. Suleja, T. Fazekas, A. Matsukawa, I. Tsuboi, R. Schulz, P. Rajwa, E. Laukhtina, M.R. Hassler, G. Marvaso, P. Sargos, P. Ost, G. Ploussard, B. Jereczek-Fossa, M. Roupret, P. Chlosta, P.I. Karakiewicz, M. Babjuk, J.Y.-. Teoh, M. Moschini, P. Gontero, S.F. Shariat
Penalized-Survival Nomogram Predicts 5-Year Metastasis-Free Survival After Salvage Radiotherapy for Postprostatectomy Patients: A Multicenter Study
2025 F. Mastroleo, R. Villa, M. Zaffaroni, M.G. Vincini, C. Franzese, L. Nicosia, F. Matrone, A. Donofrio, A. Magli, L. Triggiani, S. Barra, G. Timon, M. Augugliaro, V. Burgio, G. Francolini, M. Hasterok, M. Miszczyk, N. Simoni, C. Spatola, F. Alongi, S. Arcangeli, M. Scorsetti, G. Marvaso, B.A. Jereczek-Fossa
Impact of stereotactic body radiotherapy after progression in castrate resistant prostate cancer patients undergoing first line abiraterone treatment. A subgroup analysis from ARTO trial (NCT03449719)
2025 G. Francolini, N. Bertini, V. Di Cataldo, P. Garlatti, M. Aquilano, S. Caini, A. Bruni, G. Ingrosso, R.M. D'Angelillo, L. Tagliaferri, M. Augugliaro, L. Triggiani, S. Parisi, G. Timon, F. Arcidiacono, G. Marvaso, B.A. Jereczek-Fossa, A. Lancia, C. Franzese, F. Alongi, G. Simontacchi, D. Greto, P. Bonomo, M. Loi, G. Frosini, L. Burchini, I. Desideri, I. Meattini, R.K. Valicenti, L. Livi
ADT with SBRT versus SBRT alone for hormone-sensitive oligorecurrent prostate cancer (RADIOSA): a randomised, open-label, phase 2 clinical trial
2025 G. Marvaso, G. Corrao, M. Zaffaroni, M.G. Vincini, C. Lorubbio, S. Gandini, C. Fodor, S. Netti, D. Zerini, S. Luzzago, F.A. Mistretta, K. Venetis, G. Cursano, T. Burla, K. Mazzocco, F. Cattani, G. Petralia, N. Fusco, G. Pravettoni, G. Musi, O. De Cobelli, C. Tang, P. Ost, D.A. Palma, R. Orecchia, B.A. Jereczek-Fossa